Improving the quality of life for survivors of oropharyngeal cancer
OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship
This study is looking to improve the lives of people who have had oropharyngeal cancer linked to HPV by finding better ways to manage the tough side effects they face after treatment, so they can enjoy a better quality of life.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10933253 on NIH RePORTER |
What this research studies
This research focuses on enhancing the survivorship experience for individuals diagnosed with oropharyngeal cancer, particularly those associated with HPV. It aims to address the long-term side effects and quality of life issues that arise after treatment, which can include debilitating conditions such as dysphagia and osteoradionecrosis. The approach involves evaluating existing treatment protocols and exploring new strategies to minimize adverse effects while maintaining high survival rates. Patients will be monitored over time to assess their health outcomes and quality of life post-treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who have been diagnosed with oropharyngeal cancer, particularly those treated for HPV-related cases.
Not a fit: Patients who are currently undergoing treatment for oropharyngeal cancer or those with other unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the long-term health and quality of life for oropharyngeal cancer survivors.
How similar studies have performed: Previous research has shown that optimizing treatment protocols can lead to improved outcomes for cancer survivors, although this specific approach is still being explored.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Hutcheson, Katherine Arnold — University of Tx Md Anderson Can Ctr
- Study coordinator: Hutcheson, Katherine Arnold
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.